1
|
Cops J, De Moor B, Haesen S, Lijnen L, Wens I, Lemoine L, Reynders C, Penders J, Lambrichts I, Mullens W, Hansen D. Endurance Exercise Intervention Is Beneficial to Kidney Function in a Rat Model of Isolated Abdominal Venous Congestion: a Pilot Study. J Cardiovasc Transl Res 2019; 13:769-782. [PMID: 31848881 DOI: 10.1007/s12265-019-09947-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/02/2019] [Accepted: 12/09/2019] [Indexed: 11/24/2022]
Abstract
In this study, the effects of moderate intense endurance exercise on heart and kidney function and morphology were studied in a thoracic inferior vena cava constricted (IVCc) rat model of abdominal venous congestion. After IVC surgical constriction, eight sedentary male Sprague-Dawley IVCc rats (IVCc-SED) were compared to eight IVCc rats subjected to moderate intense endurance exercise (IVCc-MOD). Heart and kidney function was examined and renal functional reserve (RFR) was investigated by administering a high protein diet (HPD). After 12 weeks of exercise training, abdominal venous pressure, indices of body fat content, plasma cystatin C levels, and post-HPD urinary KIM-1 levels were all significantly lower in IVCc-MOD versus IVCc-SED rats (P < 0.05). RFR did not differ between both groups. The implementation of moderate intense endurance exercise in the IVCc model reduces abdominal venous pressure and is beneficial to kidney function.
Collapse
Affiliation(s)
- Jirka Cops
- BIOMED, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium. .,Faculty of Medicine and Life Sciences, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium.
| | - Bart De Moor
- BIOMED, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium.,Department of Nephrology, Jessa Ziekenhuis, 3500, Hasselt, Belgium
| | - Sibren Haesen
- BIOMED, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium.,Faculty of Medicine and Life Sciences, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium
| | - Lien Lijnen
- BIOMED, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium
| | - Inez Wens
- Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, 2000, Antwerp, Belgium
| | - Lieselotte Lemoine
- BIOMED, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium.,Department of Surgical Oncology, Ziekenhuis Oost-Limburg, 3600, Genk, Belgium
| | - Carmen Reynders
- Clinical Laboratory, Ziekenhuis Oost-Limburg, 3600, Genk, Belgium
| | - Joris Penders
- BIOMED, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium.,Clinical Laboratory, Ziekenhuis Oost-Limburg, 3600, Genk, Belgium
| | - Ivo Lambrichts
- BIOMED, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium
| | - Wilfried Mullens
- BIOMED, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium.,Department of Cardiology, Ziekenhuis Oost-Limburg, 3600, Genk, Belgium
| | - Dominique Hansen
- BIOMED, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium.,REVAL, UHasselt - Universiteit Hasselt, Agoralaan, 3590, Diepenbeek, Belgium.,Heart Centre, Jessa Ziekenhuis, 3500, Hasselt, Belgium
| |
Collapse
|
2
|
Baig S, Bert J, Gertner E. Safety of retrievable inferior vena cava filters in patients with the antiphospholipid syndrome. Eur J Rheumatol 2018; 5:100-103. [PMID: 30185357 DOI: 10.5152/eurjrheum.2018.17091] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2017] [Accepted: 10/30/2017] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVE Consideration for placement of an inferior cava filter arises in patients with APS where cessation of anticoagulation is necessary or thrombotic complications continue despite maximal anticoagulation. Permanent IVC filters are recommended to be avoided. We evaluated the safety of placement and removal of retrievable inferior vena cava filters in patients with APS. METHODS Case series of 5 patients with APS and aPL antibodies who had placement and removal of retrievable IVC filter (because of contraindication to anticoagulation or ongoing thrombosis despite full anticoagulation) to assess for safety, presence of clots in the vena cava or on the filter while in the body, evidence of PE, or clot on the explanted filter. RESULTS Insertion and removal, even while on anticoagulation, was safe. There was no evidence of clot in the vena cava, on the filter or pulmonary embolism in all cases. CONCLUSION Where necessary, retrievable IVC filters may be safer in APS patients but should not be left in for long periods of time.
Collapse
Affiliation(s)
- Sara Baig
- Department of Internal Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA
| | - Joseph Bert
- Department of Rheumatology, Regions Hospital, St. Paul, Minnesota, USA.,Department of Rheumatology, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA
| | - Elie Gertner
- Department of Rheumatology, Regions Hospital, St. Paul, Minnesota, USA.,Department of Rheumatology, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA
| |
Collapse
|
3
|
Kato M, Atsumi T. Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects. Eur J Clin Invest 2018; 48. [PMID: 29285766 DOI: 10.1111/eci.12876] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/17/2017] [Accepted: 12/10/2017] [Indexed: 02/06/2023]
Abstract
Recent studies have clarified that pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH) has some distinctive clinical aspects from other PAH, such as high prevalence, venous and cardiac involvement, less favourable outcome, helpfulness of detection algorithm, response to immunosuppression, pre-PAH conditions in borderline pulmonary arterial pressure and coexistence of interstitial lung disease. In this review, by focusing on these distinctive aspects, we discuss how to provide an efficacious and safe management of CTD-PAH and garner attention to areas where further evidence is desired.
Collapse
Affiliation(s)
- Masaru Kato
- Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
| | - Tatsuya Atsumi
- Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
| |
Collapse
|